Arca
Skip to content
Tools
Tools

Lidocaine HCl Injection USP

Recall D-0554-2026, part of FDA recall event 98976. See Spectra Medical Devices's company page.

Spectra Medical Devices, Llc started this Class II drug recall on May 12, 2026 (voluntary: firm initiated); FDA lists it as ongoing.

  • Classification: Class II
  • Started: May 12, 2026
  • Status: Ongoing

Why It Was Recalled

Class II

Lack of Assurance of Sterility

Record

Product
Lidocaine HCl Injection USP, 25x5 mL, Single-Dose Ampules, Rx Only, Distributed by: Spectra Medical Devices, LLC, Wilmington, Made in S. Korea, NDC 65282-1605-1.
Quantity
210625 ampules
Lots and codes
Lot#: AE4013, Exp 1/31/2027; AE5032 & AE5039, Exp 3/31/2028; AE5104, Exp 8/31/2028.
Distribution
USA Nationwide
Recalling firm
Spectra Medical Devices, Llc, Wilmington, MA, United States
How the firm notified
Letter
FDA classified
Jun 2, 2026

FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.